培菲替尼氢溴酸盐 98%
促销价¥{{model.attbuying.price}}
市场价¥0.00
累计销量0 累计评价0 人评论
-
{{item.title}}
| 包装规格: | 25mg 100mg in glass bottle |
| 产品简介: | 一种具有口服活性的 JAK 抑制剂,对 JAK1、JAK2、JAK3 和 Tyk2 的 IC50 值分别为 3.9、5.0、0.7 和 4.8 nM。 |
| 靶点: | JAK3:0.7 nM (IC50); JAK1:3.9 nM (IC50); Tyk2:4.8 nM (IC50); JAK2:5 nM (IC50). |
| 体外研究: | Peficitinib hydrobromide (0-100 nM; 3 days) inhibits IL-2-induced T cell proliferation in a concentration-dependent manner. Peficitinib hydrobromide (10-1000 nM) inhibits IL-2-induced STAT5 phosphorylation in a concentration-dependent manner with a mean IC50 of 124 nM in rat whole blood, and inhibits STAT5 phosphorylation with a mean IC50 of 127 nM in human lymphocytes. |
| 体内研究: | Peficitinib hydrobromide (1-30 mg/kg; p.o.; once daily for 24 days) shows dose-dependent efficacy both in prophylactic and therapeutic dosing regimens in an adjuvant-induced arthritis rat model. |
| 细胞实验: | Cell Proliferation Assay Cell Line:Splenocytes from male Lewis rats Concentration:0-100 nM Incubation Time:3 days Result:Inhibited IL-2-induced T cell proliferation in a concentration-dependent manner with an IC50 of 10 nM. |
| 动物实验: | Animal Model: Seven-weeks-old female Lewis rats, adjuvant-induced arthritis (AIA) model. Dosage:1, 3, 10, and 30 mg/kg. Administration:Oral administration, once daily for 24 days. Result:Significantly inhibited the increase in paw volume at doses of 1 mg/kg or greater with an ED50 value of 2.7 mg/kg (95% confidence interval: 1.5–4.2 mg/kg). Significantly reduced the bone destruction score at 10 mg/kg or greater and almost fully ameliorated both paw swelling and bone destruction scores at 30 mg/kg. |
| 保存条件: | -20°C |
| 注意事项: | 1、为了您的安全和健康,请穿实验服并戴一次性手套操作。 2、以上信息仅做参考交流之用。 |
-
蜀牛玻璃三角瓶
¥85.00 销量:16
-
15mL锥底离心管,袋装灭菌,橙色盖
¥636.00 销量:12
-
UFC5030BK 超滤管[0.5ml 30KD]
¥52.00 销量:10
-
UFC5010BK 超滤管[0.5ml 10KD]
¥52.00 销量:10
-
20×TBST缓冲液
¥130.00 销量:10
-
10mL移液管,易撕型全塑包装
¥456.00 销量:10
-
¥158.00
通用型 DNA 纯化回收试剂盒 -
¥158.00
质粒快速小提试剂盒 -
¥828.00
100mm TC细胞培养皿,袋装灭菌

